Chronic Fatigue Syndrome Trial, Recruiting (NCT06178952)

Chronic Fatigue Syndrome Trial, Recruiting NCT06178952 Sponsor: Medical University of Vienna Condition: Chronic Fatigue Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT06178952 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Fatigue Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to sign a consent form agreeing to take part in the study
Your COVID-19 infection was confirmed by a PCR test, a blood antibody test, or a doctor's verification
It has been at least 12 months since your first COVID-19 infection that led to your ongoing symptoms (having had COVID-19 again since then does not automatically disqualify you)
You have been diagnosed with Post-COVID Syndrome, or a general doctor or relevant specialist suspects you may have it (a formal confirmed diagnosis is not required)
You are between 20 and 80 years old
If relevant to your situation, you have taken a pregnancy test with a negative result

Who may not be able to join:

You have a pre-existing condition (present before COVID-19) that causes similar symptoms to Post-COVID and is currently causing significant health problems
You scored below 17 on a cognitive (memory and thinking) assessment, which may suggest dementia (confirm with trial site)
You scored 29 or higher on a depression questionnaire, suggesting severe depression (confirm with trial site)
You scored below 10 on a fatigue scale, suggesting you do not have significant fatigue (confirm with trial site)
You have any implants in your brain
You have metal parts in your body that are not safe for MRI scanning
You have metal parts in your head
You are currently taking blood-thinning medications (anticoagulants)
You experience claustrophobia (fear of enclosed spaces) that would prevent you from having an MRI scan
You have a pacemaker that is not safe for use in an MRI scanner
You are currently pregnant or breastfeeding
You have had significant surgery on your head, heart, or blood vessels
You have taken steroid (corticosteroid) medications within the 6 weeks before the study would begin
You have a tumour in your head that is relevant to your treatment (confirm with trial site)
You have a condition that affects how your blood clots
You are currently taking part in another clinical study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Roland Beisteiner, Prof., Medical University of Vienna

Phone: +43/(0)1 40400-34080

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06178952

Sponsor: Medical University of Vienna

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Fatigue Syndrome

Trial contact: +43/(0)1 40400-34080

More information: https://clinicaltrials.gov/study/NCT06178952

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to sign a consent form agreeing to take part in the study
Your COVID-19 infection was confirmed by a PCR test, a blood antibody test, or a doctor's verification
It has been at least 12 months since your first COVID-19 infection that led to your ongoing symptoms (having had COVID-19 again since then does not automatically disqualify you)
You have been diagnosed with Post-COVID Syndrome, or a general doctor or relevant specialist suspects you may have it (a formal confirmed diagnosis is not required)
You are between 20 and 80 years old
If relevant to your situation, you have taken a pregnancy test with a negative result

Who may not be able to join:

You have a pre-existing condition (present before COVID-19) that causes similar symptoms to Post-COVID and is currently causing significant health problems
You scored below 17 on a cognitive (memory and thinking) assessment, which may suggest dementia (confirm with trial site)
You scored 29 or higher on a depression questionnaire, suggesting severe depression (confirm with trial site)
You scored below 10 on a fatigue scale, suggesting you do not have significant fatigue (confirm with trial site)
You have any implants in your brain
You have metal parts in your body that are not safe for MRI scanning
You have metal parts in your head
You are currently taking blood-thinning medications (anticoagulants)
You experience claustrophobia (fear of enclosed spaces) that would prevent you from having an MRI scan
You have a pacemaker that is not safe for use in an MRI scanner
You are currently pregnant or breastfeeding
You have had significant surgery on your head, heart, or blood vessels
You have taken steroid (corticosteroid) medications within the 6 weeks before the study would begin
You have a tumour in your head that is relevant to your treatment (confirm with trial site)
You have a condition that affects how your blood clots
You are currently taking part in another clinical study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical University of Vienna

Registry

ClinicalTrials.gov

Start date

8 January 2024

Est. completion

1 January 2027

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Fatigue Impact Scale (FIS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov